Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Chao Qin has a total of 109 co-authors. Here are the top co-authors by number of shared publications:

  • Ziming Ye

    Department of Neurology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Province, China

    7 shared publications
  • Chao Xiao

    Department of Neurology, the First Affiliated Hospital of Guangxi Medical University, Nanning, China

    6 shared publications
  • Hao-Wei Deng

    Department of Neurology, the First Affiliated Hospital of Guangxi Medical University, Nanning, China

    5 shared publications
  • Rui-Ting Hu

    Department of Neurology, Minzu Hospital of Guangxi Medical University, Nanning, China

    4 shared publications
  • Shao-Dan Zhou

    Department of Neurology, Minzu Hospital of Guangxi Zhuang Autonomous Region

    4 shared publications
  • Songxin Zhong

    Department of Neurology, the First Affiliated Hospital of Guangxi Medical University, Nanning, China

    4 shared publications

Latest Publications

  • Open Access

    Association between metabolic-inflammatory indices and new-onset stroke

    by Xiaomin Feng, Chao Xiao, Songxin Zhong, Chao Qin

    Metabolic–inflammatory dysregulation contributes to atherosclerosis, endothelial dysfunction, and pro-thrombotic states that elevate cerebrovascular risk. To explore the association between metabolic inflammation and new-onset stroke, we investigated 4 emerging indicators – the C-reactive protein-triglyceride glucose index (CTI), platelet-to-high-density lipoprotein-cholesterol ratio (PHR), body roundness index (BRI), and a body shape index (ABSI) – and evaluated their relationships with new-onset stroke. Data were derived from the China Health and Retirement Longitudinal Study (CHARLS) waves of 2011 and 2018. A total of 7365 individuals aged 45 years and older were included in the follow-up cohort. Logistic regression models were used to examine the associations between selected indicators and new-onset stroke, with subgroup analyses stratified by gender. Smoothed curve fitting was used to explore potential nonlinear relationships. The models were adjusted for confounding factors, and sensitivity analyses were performed to assess the robustness of the findings. During the 7-year follow-up period, a total of 545 participants experienced an incident stroke. Across all 3 logistic regression models, CTI, BRI, and PHR were positively associated with increased stroke risk. In the fully adjusted model, participants in the highest quartile of CTI (Q4) had a significantly higher risk compared to those in the lowest quartile (Q1), with an odds ratio (OR) of 2.054 (95% confidence interval [CI]: 1.546–2.729). Similarly, the highest quartiles of BRI and PHR were also significantly associated with increased stroke risk, with BRI Q4 showing an OR of 1.721 (95% CI: 1.296–2.284) and PHR Q4 showing an OR of 1.562 (95% CI: 1.215–2.009). CTI showed the strongest association with incident stroke among the evaluated indicators and exhibited a nonlinear relationship with stroke risk. A data-derived inflection point was identified at CTI = 8.806. Below this value, higher CTI was significantly associated with increased stroke risk (OR = 1.925, 95% CI: 1.469–2.523). Gender-stratified analyses further confirmed a consistent positive association between CTI and stroke risk in both men and women. ABSI showed no significant association with incident stroke. CTI, BRI, and PHR were significantly and positively associated with new-onset stroke, with CTI showing the strongest association among the evaluated indicators. ABSI showed no significant association.

  • Open Access

    Development and external validation of a machine learning-based model for identifying advanced Parkinson’s disease

    by Xiao-Ru Tan, Shao-Dan Zhou, Bing-Hua Lv, Fu-Zan Wei, Wen-Bin Teng, Chao Qin, Rui-Ting Hu

    Background: Identifying patients with advanced stage in Parkinson’s disease (PD) is crucial for timely therapeutic intervention, yet current tools rely on subjective clinical scales or expensive biomarkers. We aimed to develop and validate a predictive model based on routine blood biomarkers selected by machine learning algorithms. Methods: We retrospectively analyzed data from 536 PD patients in a discovery cohort and 80 patients in an independent external validation cohort. Patients were classified as having early or advanced stage based on Hoehn and Yahr staging scale. LASSO and Random Forest (RF) algorithms were employed to screen predictors from demographic and routine blood variables. Selected features were integrated into a multivariable logistic regression model to construct a predictive model. Model performance was evaluated using the AUC, calibration curves, and decision curve analysis (DCA). Results: Six biomarkers including total bilirubin (TB), indirect bilirubin (IBIL), albumin (ALB), cholinesterase (ChE), lactate dehydrogenase (LDH), and creatine kinase (CK), were identified as independent predictors based on LASSO and RF algorithms. The predictive model demonstrated excellent discriminative ability in the discovery cohort (AUC = 0.873) and maintained robust performance in the external validation cohort (AUC = 0.736). Calibration curve showed good agreement between predicted probabilities and observed outcomes. DCA confirmed the clinical net benefit of the model across a wide range of threshold probabilities. Notably, advanced-stage patients exhibited significantly higher levels of TB, IBIL, ALB, and ChE, but lower levels of LDH compared to early-stage patients. Conclusion: We established a reliable, non-invasive, and economically efficient predictive model using six blood biomarkers to identify advanced PD.

  • Open Access

    Efficacy and Safety of Endovascular Recanalization for Non-acute Intracranial Arterial Occlusion: A Systematic Review and Meta-Analysis

    by Xiuen Chen, Ting Zhou, Chao Xiao, Yining Lan, Dandan Chen, Jing Lu, Ziming Ye, Chao Qin

  • Open Access

    Global burden of stroke attributable to air pollution (1990–2021): An analysis of GBD 2021 data

    by Changqiang Feng, Songxin Zhong, Chao Xiao, Rida Li, Xiaomin Feng, Shizhan Li, Zukun He, Yijiu Lu, Jianqing Zhu, Yanni Lin, et al.

    This study aims to quantify the global burden of stroke attributable to air pollution and assess associated health disparities by region, gender, and socio-demographic index using 2021 Global Burden of Disease data. We conducted a systematic analysis of the 2021 Global Burden of Disease database, employing Joinpoint regression, decomposition analysis, and health inequality analysis to evaluate air pollution’s impact on stroke mortality and disability-adjusted life years. Analyses were stratified by nationality, region, gender, and socio-demographic index to identify health disparities. The study findings demonstrate a substantial increase in the global absolute burden of stroke attributable to air pollution from 1991 to 2021, with stroke-related mortality reaching 44,962,167 cases (95% uncertainty interval: 35,020,339–55,467,024) and disability-adjusted life years amounting to 44,962,167 person-years (95% uncertainty interval: 35,020,339–55,467,024). Notably, regional disparities in stroke burden have become increasingly pronounced. Furthermore, the disease burden was significantly higher among male patients compared to females, highlighting the critical role of gender disparities in the health impacts of stroke. Based on these findings, we recommend enhancing air pollution monitoring and control, strengthening health system resilience, and promoting targeted public health interventions. This study provides a scientific foundation for formulating prevention strategies against air pollution-related stroke and calls for strengthened global cooperation to address this critical public health challenge.


  • Open Access

    Impact of rheumatoid arthritis on Alzheimer’s disease: A two-sample bidirectional Mendelian randomization study

    by Songxin Zhong, Changqiang Feng, Shizhan Li, Yanni Lin, Jianqing Zhu, Xia Liang, Chao Qin

    Controversial relationship of rheumatoid arthritis (RA) with Alzheimer disease (AD) risk has been reported in previous research. However, epidemiological studies are susceptible to confounding factors and reverse causality. This study aimed to explore the causal relationship between RA and AD by using a 2-sample bidirectional Mendelian randomization (MR) study. Genetic data for RA and AD were extracted from published genome-wide association study databases and the FinnGen project. The primary statistical method was inverse variance weighted, which was supplemented by MR Egger regression, weighted median, simple mode, and weighted mode methods. In addition, Cochran Q test, MR Egger intercept, and MR-PRESSO global test were used to detect heterogeneity and pleiotropy. Further sensitivity analyses were conducted using leave-one-out method and funnel plots, to evaluate the robustness of the results. Genetically predicted RA had a positive casual effect on the risk of AD development (inverse variance weighted odds ratio [OR] = 1.062, 95% confidence interval [CI] = 1.019–1.107, P = .004; weighted median OR = 1.073, 95% CI = 1.021–1.126, P = .005; weighted mode OR = 1.077, 95% CI = 1.025–1.131, P = .007). Notably, reverse MR analysis indicated no significant effect of AD on RA (all P > .05). No pleiotropy or heterogeneity was identified in the bidirectional MR analysis. And leave-one-out analysis and funnel plots confirmed the robustness and reliability of the findings. This study provides new evidence for the causal relationship between RA and the increased risk of AD. Early screening of cognitive function in patients with RA may be beneficial in preventing future AD progression.


  • Open Access

    Cortical morphometric similarity patterns and molecular signatures across ischemic stroke recovery

    by Xiuen Chen, Jialan Liang, Chengdi Deng, Zhilin Yu, Ziming Ye, Chao Qin, Yanyan Tang

    Background: Ischemic stroke is associated with widespread and dynamic brain structural alterations, but the relationship between these changes and underlying molecular signatures across different post-stroke stages remains unclear. Therefore, we examined the brain structural difference of patients with 3 T high resolution magnetic resonance, further explored special molecular signatures across ischemic stroke recovery stages. Methods: Among 170 participants were recruited, including 60 acute/subacute ischemic stroke patients, 59 chronic ischemic stroke patients, and 51 healthy controls. Morphometric similarity networks (MSNs) were constructed by calculating Pearson correlations between cortical morphometric feature vectors across 308 regions. Group differences in MSN strength were assessed using covariate-adjusted linear regression. We further applied partial least squares regression to link regional MSN differences with gene expression data from the Allen Human Brain Atlas, identifying molecular signatures across ischemic stroke recovery stages. Results: Regional MSN differences differed by stroke stage, predominantly involving frontal-temporal cortices in acute/subacute ischemic stroke and widespread cortical areas in chronic ischemic stroke. Regional MSN differences were associated with cortical transcriptional gradients, identifying key stroke-related genes (e.g., KIF5B, C4orf3, APMAP, STOML1). Functional analysis highlighted molecular signatures linked to neuronal changing, axonal transport, and protein homeostasis. Conclusion: Our findings demonstrate stage-specific morphometric differences and molecular signatures associated with different stages of ischemic stroke, highlighting regionally distinct structural and transcriptomic associations. These insights may facilitate targeted interventions aimed at improving functional outcomes across different stages of stroke.


  • Open Access

    A machine learning-based predictive nomogram for early neurological improvement after thrombolysis in acute ischemic stroke

    by Bing-Hua Lv, Hao-Wei Deng, Zuo-Yv Qin, Ning-Qin Meng, Gui-Ming Weng, Rui-Ting Hu, Chao Qin

    Background: Early neurological improvement (ENI) is a critical prognostic indicator for acute ischemic stroke (AIS) patients undergoing intravenous thrombolysis with recombinant tissue plasminogen activator (rt-PA). This study aimed to develop and validate a machine learning (ML)-based model for predicting ENI using clinical and biochemical data. Methods: Clinical data from 217 AIS patients (97 ENI, 120 non-ENI) were retrospectively analyzed. Significant baseline differences were identified between groups, including hemorrhage, onset-to-needle time (ONT), neutrophil-to-lymphocyte ratio (NLR), weight, and activated partial thromboplastin time (APTT). Four ML algorithms, including Multilayer Perceptron (MLP), Random Forest (RF), Support Vector Machine (SVM), and XGBoost, were implemented. Model performance was evaluated via area under the receiver operating characteristic curve (AUC). Key predictors were identified by intersecting top-ranked features from all algorithms, followed by logistic regression modeling and nomogram visualization. Results: The MLP model achieved the highest AUC (0.77) in the testing set, outperforming RF (0.72), SVM (0.63), and XGBoost (0.68). Six overlapping parameters, including APTT, ALT/AST ratio, ONT, mean corpuscular hemoglobin concentration (MCHC), weight, and NLR, were selected as core predictors. The logistic regression model incorporating these parameters yielded an AUC of 0.74, while the nomogram demonstrated that the predictive model exhibited strong discriminative ability (C-index: 0.817) for predicting ENI in rt-PA-treated AIS patients. Conclusion: This ML-based model effectively predicts ENI in rt-PA-treated AIS patients by integrating critical clinical and biochemical markers. Its application may optimize personalized treatment strategies, enhance clinical decision-making, and improve patient outcomes.


  • Open Access

    Impact of smoking and alcohol consumption on telomere length: A univariable and multivariable Mendelian randomization study

    by Changqiang Feng, Songxin Zhong, Rida Li, Yanni Lin, Jianqing Zhu, Xia Liang, Chao Xiao, Chao Qin

    Telomere length is a potential biomarker for biological aging and is associated with many age-related pathologies. Although observational evidence has linked modifiable lifestyle factors to telomere attrition, the causal relationship between smoking, alcohol consumption, and telomere length remains controversial. This study aimed to investigate the causal effects of smoking and alcohol consumption on telomere length using Mendelian randomization (MR) analysis. Genetic data on smoking initiation (N = 805,431), alcohol consumption (N = 666,978), and telomere length (N = 472,174) were extracted from published summary statistics. Univariable and multivariable MR analyses were performed to comprehensively estimate the independent causal effects of smoking and alcohol consumption on telomere length. Cochran Q test and the MR Egger intercept test were used to detect heterogeneity and pleiotropy. A Steiger filtering test was conducted to confirm directional causal effects. Further sensitivity analyses were performed using the leave-one-out method and funnel plots. Inverse variance weighted (IVW) analysis showed that genetically predicted smoking initiation was significantly associated with shorter telomere length (univariable IVW: β = −0.08, 95% confidence interval [CI] = −0.11 to −0.04, P < .001; multivariable IVW: β = −0.06, 95% CI = −0.11 to −0.02, P = .007). Similarly, genetic predisposition to alcohol consumption was causally associated with shorter telomere length (univariable IVW: β = −0.06, 95% CI = −0.10 to −0.02, P = .006; multivariable IVW: β = −0.06, 95% CI = −0.11 to −0.01, P = .030). No pleiotropy was identified in either univariable or multivariable MR analyses. The Steiger filtering test validated the accuracy of directional causality ( P < .001). Finally, leave-one-out analysis and funnel plots further confirmed the robustness and reliability of the findings. This study provides genetic evidence for the causal effects of smoking and alcohol consumption on telomere shortening. Interventions targeting tobacco smoking and alcohol consumption may slow down cellular senescence and mitigate the risk of age-related diseases.


  • Open Access

    Global burden of ischemic stroke in adults aged 60 years and older from 1990 to 2021: Population-based study

    by Xiuen Chen, Lizhi Lu, Chao Xiao, Yining Lan, Songxin Zhong, Chao Qin, Yanyan Tang

    Background: Ischemic stroke is an important public health problem. However, comprehensive data on its burden in aging populations is limited. The aim of this study is to provide an up-to-date assessment of the prevalence, incidence, mortality, disability-adjusted life years, and risk factors for ischemic stroke globally in adults aged 60 years and older from 1990 to 2021 based on population changes. Methods: The Global Burden of Diseases, Injuries, and Risk Factors Study 2021 served as the data source for this study. Average annual percentage changes were estimated over the study period to quantify temporal patterns and assess trends in age-standardized rates of the prevalence, incidence, mortality, and disability-adjusted life-years of ischemic stroke. Results: The significant increase in the prevalence and incidence of ischemic stroke is mainly related to population ageing and the significant increase in the number of people over 60 years of age, with the significant increase in the population over 60 years of age being the main driving force, while epidemiological changes have had the opposite effect. Critically, using the entire age population for calculations will prompt us to underestimate the burden of ischemic stroke. The burden of ischemic stroke disease is highest in older men than in older women, and the age-standardized prevalence rates, incidence rates, mortality rates, and disability-adjusted life-years rates are 26–35% higher in men than in women. High-middle sociodemographic index and Sub-Saharan Africa regions suffer the heaviest burden. Ischemic stroke health inequities widen, with less developed regions bearing a heavier ischemic stroke burden and the disparity in that burden becoming more pronounced over time. Conclusion: Population aging is the primary driver of the growing burden of ischemic stroke. Our findings indicate that prevention and control of this disease remain critical public health challenges. Targeted interventions addressing modifiable risk factors could significantly reduce the global burden of ischemic stroke.


  • Open Access

    The global, regional, and national burdens of dementia in 204 countries and territories from 1990 to 2021: A trend analysis based on the Global Burden of Disease Study 2021

    by Songxin Zhong, Chao Xiao, Rida Li, Yining Lan, Chi Gong, Changqiang Feng, Hengchang Qi, Yanni Lin, Chao Qin

    The global population is aging, and as a consequence, the prevalence of dementia is increasing rapidly. This study aims to analyze trends in the Global Burden of Disease (GBD) and health inequalities for dementia over the period 1990 to 2021. The incidence, prevalence, and disability-adjusted life year rates of dementia in the GBD 2021 database were analyzed at the global, national, and regional levels for the period 1990 to 2021 using Joinpoint 4.9.1.0 software. The trends over the period were assessed using a combination of age-standardized rates, average annual percentage changes (AAPCs), and a sociodemographic index. The analysis revealed that, from 1990 to 2021, the global AAPC in dementia incidence, prevalence, and disability-adjusted life years amounted to 0.06 (95% confidence interval [CI]: 0.05–0.09), 0.09 (95% CI: 0.08–0.10), and 0.03 (95% CI: 0.01–0.05), respectively. Conversely, the mean AAPC in age-standardized mortality rate remained stable at 0 (95% CI: −0.02 to 0.03). The age-standardized incidence rate and age-standardized prevalence rate of dementia exhibited a positive association with sociodemographic index during the study period. The 3 regions with the highest mean AAPC in age-standardized mortality rate among the 21 GBD regions were South Africa, Central Sub-Saharan Africa, and Eastern Sub-Saharan Africa. The findings of the study indicate that the burden of dementia increases with age and is projected to remain on an upward trend until 2040. The GBD has increased significantly from 1990 to 2021, and the prevention and control of dementia represents a long-term and formidable challenge.